Work

High throughput hybridoma cultivation

Year: 2022
Type: dissertation
Abstract: Proteins developed in the Human Secretome Project can be injected in mice, in order to develop monoclonal antibodies, mAbs. Through fusion with murine myeloma cells and B cells, forming hybridomas, large amounts of mAbs against a specific antigen can be produced. This contributes to a library of targets for these proteins developed in the Human Secretome Project. In the pharmaceutical industry, mAbs are often used as therapeutic and clinical agents. Hybridoma technology is one of the most common methods regarding production of mAbs. However, as far as the performed literature study can tell, the cultivation of hybridomas have mostly been optimized to cultivate a few clones, and not in the aim of cultivating several hybridomas in parallel. In this report, a protocol on cultivating 24 hybridomas in parallel will be presented. The protocol includes optimization of medium type, adaptation between mediums, type of shake flask, choice of measuring production titer and type of purification method suitable for high-throughput. High-throughput focuses on methods which allow a parallel and cost-efficient processing of numerous samples. The results will be obtained by performing a literature study. The hybridomas are received as aliquots stored in liquid nitrogen, containing 10% fetal bovine serum in Dulbecco’s modified Eagle’s medium. Then, the aliquots will be thawed and cultivated adherently in T-flask (made of polystyrene) until reaching a desirable cell concentration. Thereafter, the hybridomas will be adapted to a suspension culture in Erlenmeyer flask (made by single-use polycarbonate) to reach a cell concentration of (3-9) x 105 cells/mL, until a final volume of 50-200 mL is given. After that, the cells should be sequentially adapted to a new serum-free medium by reducing the concentration of fetal bovine serum with 50% every passage. A fed-batch will be applied, with a pH of 7.4, 5-7% CO2 in air and a temperature at 36.5°C to avoid overheating, since cells derived from the mouse’s spleen have a core temperature at 36.6°C according to Reitman (2018). According to studies, for instance one by El-Enshasy et al. (2006), when adjusting the osmolarity stepwise, from 300 to 366 mOsmol 1/kg followed by 366 mOsmol 1/kg to 440 mOsmol 1/kg, a higher cell density is reached compared to no adjustment being made. Consequently, the production of mAbs increases. During the cultivation process, hybridomas secrete antibodies at a concentration of 0.1-1 mg/mL culture medium according to a study from Mak and Saunders (2006). The measurement of production titer will be provided with help of the Octet® Bio-Layer Interferometry (BLI) systems which is an optical technique that analyzes the interference pattern of white light that is reflected from an immobilized protein on a biosensor tip and an internal reference layer. The concentration of antibodies is counted through a comparison of the phase shift wavelength that each interference pattern causes. Further, the mAbs will be purified using the Protein Maker with compatible Protein G column, for instance HiTrap Protein G HP Antibody Purification (5 mL) in tandem which gives a yield of 80-95% according to studies from Hélie at al. (2016) and Yang et al. (2021). Through calculations (see appendix 8.1.2), this would provide an amount of mAbs in the range of 4-190 mg per shake flask after purification, assuming a volume of subculture in the range of 50-200 mL.
Authors: Lindbom, Elin, He, Julia, Ericsson, Linda, Al-Haddad, Mariam
Language: English
Subfield: Immunology
Open Access status: green
OpenAlex ID: W7028881249
Cites:
Cited by:
Related to: 10